Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Wednesday, September 2, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Pharma
Pharma
Pharma
AstraZeneca Completes Global Licensing Deal for Lung Cancer Drug ZEGFROVY
Life Sciences Times
-
September 1, 2026
Pharma
Vertex Completes $10 Billion Acquisition of Crinetics, Expands Leadership Team
Life Sciences Times
-
September 1, 2026
Pharma
Ascletis Doses First Participant in Global Phase 3 Program for Oral GLP-1 Drug ASC30
Life Sciences Times
-
August 31, 2026
Pharma
Amgen Reports Repatha Reduced Risk of Death in High-Risk Patients Without Prior Heart Attack or Stroke
Life Sciences Times
-
August 31, 2026
Pharma
Lilly Reports One-Year Phase 3b Data for Taltz and Zepbound in Psoriatic Disease and Obesity
Life Sciences Times
-
August 31, 2026
Pharma
Bristol Myers Squibb Plans $2.3 Billion Manufacturing Campus in Houston
Life Sciences Times
-
August 10, 2026
0
Pharma
FDA Approves Takeda’s ORZEYFUL for Narcolepsy Type 1
Life Sciences Times
-
August 6, 2026
0
Pharma
Amylyx Reports $43.4 Million Q2 Loss as Phase 3 Avexitide Data Near
Life Sciences Times
-
August 6, 2026
0
Pharma
Ono Pharma, Mediar Therapeutics Partner on Antibody Drugs for Fibro-inflammatory Diseases
Life Sciences Times
-
August 6, 2026
0
Pharma
Ironwood Raises 2026 Outlook as Q2 Revenue, Profit Climb
Life Sciences Times
-
August 6, 2026
0
Pharma
Apnimed Prices Upsized IPO at $16 Per Share, Raising $192 Million
Life Sciences Times
-
August 3, 2026
0
Pharma
Meitheal Pharmaceuticals Wins FDA Approval for Garzulys Insulin Biosimilar
Life Sciences Times
-
July 31, 2026
0
Pharma
Sumitomo Pharma’s Enzomenib Receives FDA Orphan Drug Designation for Acute Lymphoblastic Leukemia
Life Sciences Times
-
July 30, 2026
0
Pharma
Alnylam Reports 74% Revenue Growth in Second Quarter, Lowers 2026 TTR Outlook
Life Sciences Times
-
July 30, 2026
0
People on the Move
Alkermes Reports $496 Million in Second-Quarter Revenue, Names Blair Jackson as Next CEO
Life Sciences Times
-
July 28, 2026
0
Pharma
FDA Approves Otsuka’s Simtriyo for ADHD in Adults and Children
Life Sciences Times
-
July 27, 2026
0
Pharma
AstraZeneca H1 Revenue Rises 9% as Oncology and Rare Disease Sales Drive Growth
Life Sciences Times
-
July 27, 2026
0
1
2
3
...
99
Page 2 of 99
Most Read
Flosonics Medical Partners With BARDA on AI-Enabled Trauma Technology for FloPatch
September 1, 2026
Tobias Janowitz Named Director of Feinstein Institutes’ Cancer Research Institute
September 1, 2026
AstraZeneca Completes Global Licensing Deal for Lung Cancer Drug ZEGFROVY
September 1, 2026
Greater Boston Urology Adds Dr. Akash Sharma and Dr. Rafael Tua-Caraccia
September 1, 2026